Stock Events

Stock Events

Merrimack Pharmaceuticals (MACK) Q3 2023 Earnings

Nov 2Confirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-0.03

-0.03

-0.02

-0.02

Details

Expected EPS

N/A

Actual EPS

-0.02

Surprise EPS

N/A

Surprise Percent

N/A

Description

⁨Merrimack Pharmaceuticals⁩ (⁦MACK⁩) has reported earnings of ⁦-0.02⁩ per share for ⁦Q3 2023⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.